Evidence map›Paper›PMID 33950336›Full record

ArticleJournal of neurology2021

The impact of Coronavirus disease 2019 (COVID-19) pandemic on migraine disorder.

Faraidoon Haghdoost, Cheryl Carcel, Deepak Chandrasekhar, Anthony Rodgers, Candice Delcourt

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Reply to correspondence "Contributing factors towards progression of migraines during the Covid-19 pandemic".Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2022
    Article
  3. The impacts of masks and disinfectants on migraine patients in the COVID-19 pandemic.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2022
    Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Faraidoon HaghdoostThe George Institute for Global Health, The University of New South Wales, Sydney, NSW, Australia.
Cheryl CarcelThe George Institute for Global Health, The University of New South Wales, Royal Prince Alfred Hospital, The University of Sydney, Sydney, NSW, Australia.
Deepak ChandrasekharHealint Pte Ltd, Singapore, Singapore.
Anthony Rodgers *The George Institute for Global Health, The University of New South Wales, Sydney, NSW, Australia.
Candice DelcourtThe George Institute for Global Health, The University of New South Wales, Sydney, NSW, Australia. cdelcourt@georgeinstitute.org.au.ORCID http://orcid.org/0000-0003-2257-4286
UNSW Sydney · AUThe George Institute for Global Health · AUThe University of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the impact of the Coronavirus disease of 2019 (COVID-19) pandemic on patients with migraine.

methodsSelf-reported data from a migraine tracking smartphone application, Migraine Buddy, were used. Data were collected from users who reported at least one attack in the Jan, Feb, Mar and Apr of 2018, 2019 and 2020. In addition, a survey was conducted to evaluate the impact of COVID-19 on migraine management.

resultsOn average, data from 124,717 users per month (mean age 36.3 ± 10.9 years and 89% female) were collected. Overall, the mean frequency of migraine headache was higher in 2020 than in 2019 and higher in 2019 than in 2018. The four commonest headache triggers in 2018, 2019 and 2020 were stress in 39.7, 38.4 and 36.1%, lack of sleep in 25, 25 and 22.8%, neck pain, 20, 20.4 and 19.3 and anxiety in 19, 18.4 and 18.4% of participants, respectively. 1689 users participated in the survey and they reported that they preferred face-to-face (54.29%) to telehealth (11.9%) consultations.

conclusionAn increase in migraine frequency from 2018 to 2020 was reported by the users of the mobile phone. This could reflect a real increase or change in reporting habits. Stress, lack of sleep, neck pain and anxiety were the commonest attack triggers. The frequency of these triggers decreased slightly in 2020 compared to 2019 and 2018. An increase in telehealth consultations with specialists was reported in the survey but migraine patients preferred face-to-face consultations.

Indexed as

COVID-19Migraine DisordersAdultFemaleHeadacheHumansMaleMiddle AgedPandemicsSARS-CoV-2AnxietyCOVID-19FrequencyHeadacheMigraineStressTrigger

Identifiers

PMID33950336
PMCPMC8098636
OpenAlexW3159243772

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.